✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Divi's Laboratories Ltd.

DIVISLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,71,847 Cr.
P/E
69.15

Divi's Laboratories Ltd.

  • Divi's Lab
  • Laurus Labs
  • Neuland Laboratories
  • TJI Pharma - API & CRAMS

FAQs on Divi's Laboratories Ltd. Shareprice

Divi's Lab has given lower returns compared to its competitors.
Divi's Lab has grown at ~31.66% over the last 2yrs while peers have grown at a median rate of 32.64%

Yes, Divi's Lab is expensive.
Latest PE of Divi's Lab is 69.15, while 3 year average PE is 60.61.
Also latest EV/EBITDA of Divi's Lab is 51.96 while 3yr average is 42.89.

View FAQ's On Business

Growth Table

  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Balance Sheet

  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Cash Flow

  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Quarterly Results

  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Divi's Laboratories Ltd. Financials

Balance sheet of Divi's Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Divi's Lab is increasing.
Latest net debt of Divi's Lab is -₹3,172 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹7,427 Crs.

Yes, profit is increasing.
The profit of Divi's Lab is ₹2,485 Crs for TTM, ₹2,191 Crs for Mar 2025 and ₹1,600 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Divi's Lab latest dividend payout ratio is 36.28% and 3yr average dividend payout ratio is 43.19%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech